BetterLife Pharma Inc. (BETRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0580
-0.0020 (-3.33%)
Jul 3, 2025, 12:34 PM EDT
BetterLife Pharma Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
Cost of Revenue | - | - | - | - | - | 0.02 | Upgrade
|
Gross Profit | - | - | - | - | - | -0.02 | Upgrade
|
Selling, General & Admin | 2.61 | 4.3 | 2.64 | 6.56 | 4.53 | 7.56 | Upgrade
|
Research & Development | 0.32 | 0.42 | 0.57 | 2.68 | 5.42 | 0.28 | Upgrade
|
Operating Expenses | 2.93 | 4.72 | 3.21 | 9.26 | 9.97 | 7.93 | Upgrade
|
Operating Income | -2.93 | -4.72 | -3.21 | -9.26 | -9.97 | -7.95 | Upgrade
|
Interest Expense | -0.33 | -0.32 | -0.05 | -0.07 | -0.06 | -0.04 | Upgrade
|
Interest & Investment Income | - | - | - | - | - | 0 | Upgrade
|
Currency Exchange Gain (Loss) | -0.06 | -0.28 | -0.03 | -0.2 | -0.24 | 0.04 | Upgrade
|
Other Non Operating Income (Expenses) | 0.84 | 0.73 | -0.17 | -0 | -1.07 | -0.3 | Upgrade
|
EBT Excluding Unusual Items | -2.48 | -4.59 | -3.46 | -9.53 | -11.33 | -8.25 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | 0.19 | -15.86 | Upgrade
|
Asset Writedown | - | - | - | - | - | -12.12 | Upgrade
|
Legal Settlements | 0.56 | 0.56 | 0.13 | 0.26 | -0.56 | -0.12 | Upgrade
|
Other Unusual Items | 0.15 | 0.42 | 0.44 | -0.1 | -0.29 | - | Upgrade
|
Pretax Income | -1.78 | -3.62 | -2.9 | -9.37 | -11.99 | -36.35 | Upgrade
|
Income Tax Expense | - | - | - | - | 0.17 | - | Upgrade
|
Earnings From Continuing Operations | -1.78 | -3.62 | -2.9 | -9.37 | -12.16 | -36.35 | Upgrade
|
Minority Interest in Earnings | -0.01 | 0.1 | 0.01 | 0.36 | - | - | Upgrade
|
Net Income | -1.78 | -3.52 | -2.89 | -9.02 | -12.16 | -36.35 | Upgrade
|
Net Income to Common | -1.78 | -3.52 | -2.89 | -9.02 | -12.16 | -36.35 | Upgrade
|
Shares Outstanding (Basic) | 127 | 124 | 109 | 87 | 75 | 27 | Upgrade
|
Shares Outstanding (Diluted) | 127 | 124 | 109 | 87 | 75 | 27 | Upgrade
|
Shares Change (YoY) | 12.50% | 13.34% | 26.25% | 14.70% | 179.24% | 79.75% | Upgrade
|
EPS (Basic) | -0.01 | -0.03 | -0.03 | -0.10 | -0.16 | -1.34 | Upgrade
|
EPS (Diluted) | -0.01 | -0.03 | -0.03 | -0.10 | -0.16 | -1.34 | Upgrade
|
Free Cash Flow | -1.18 | -2.02 | -2.47 | -1.5 | -11.2 | -7.18 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.02 | -0.15 | -0.27 | Upgrade
|
EBITDA | - | - | -3.19 | -9.24 | -9.95 | -7.8 | Upgrade
|
D&A For EBITDA | - | - | 0.02 | 0.02 | 0.02 | 0.16 | Upgrade
|
EBIT | -2.93 | -4.72 | -3.21 | -9.26 | -9.97 | -7.95 | Upgrade
|
Advertising Expenses | - | - | - | 0.12 | 0.44 | 0.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.